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OBJECTIVE — Disposition index (DI) and glucose effectiveness (SG) are risk factors for
diabetes. However, the effect of DI and SG on future diabetes has not been examined in large
epidemiological studies using direct measures.
RESEARCH DESIGN AND METHODS — Insulin sensitivity index (SI), acute insulin
response (AIR), and SG were measured in 826 participants (aged 40–69 years) in the Insulin
ResistanceAtherosclerosisStudy(IRAS)bythefrequentlysampledintravenousglucosetolerance
test.DIwasexpressedasSIAIR.Atthe5-yearfollow-upexamination,128individuals(15.5%)
had developed diabetes.
RESULTS — TheareaunderthereceiveroperatingcharacteristiccurveofamodelwithSIand
AIR was similar to that of DI (0.767 vs. 0.774, P  0.543). In a multivariate logistic regression
model that included both DI and SG, conversion to diabetes was predicted by both SG (odds
ratio  1 SD, 0.61 [0.47–0.80]) and DI (0.68 [0.54–0.85]) after adjusting for demographic
variables, fasting and 2-h glucose concentrations, family history of diabetes, and measures of
obesity. Age, sex, race/ethnicity, glucose tolerance status, obesity, and family history of diabetes
did not have a signiﬁcant modifying impact on the relation of SG and DI to incident diabetes.
CONCLUSIONS — The predictive power of DI is comparable to that of its components, SI
and AIR. SG and DI independently predict conversion to diabetes similarly across race/ethnic
groups, varying states of glucose tolerance, family history of diabetes, and obesity.
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B
oth insulin sensitivity and ﬁrst-
phaseinsulinsecretionareindepen-
dent determinants of conversion to
diabetes in different ethnic groups and
varying states of glucose tolerance, family
history of diabetes, and obesity (1). First-
phase insulin secretion compensates for
theworseningofinsulinsensitivity(2).In
studies using direct methods, such as the
frequently sampled intravenous glucose
tolerance test (FSIGTT) with minimal
model analysis, this relationship is hyper-
bolic (2) and similar across glucose toler-
ance categories (3). Known as the
disposition index (DI), the product of
measures of insulin sensitivity and ﬁrst-
phaseinsulinsecretion,ithasbeenshown
to predict conversion to diabetes (4–6).
Theevidence,however,comesfromstud-
ies that have enrolled relatively few par-
ticipantsortargetedpersonsfromasingle
ethnic group. Since direct methods have
demanding technical requirements, the
product of measures of insulin sensitivity
and insulin secretion derived from the
oral glucose tolerance test has attracted
interest. This product has been shown to
have a modest correlation with minimal
model–derived DI, to decrease as glucose
tolerance status deteriorates, and to pre-
dict the development of diabetes inde-
pendent of other risk factors including
fasting and 2-h glucose concentrations
(7,8). It includes the incretin effect and
therefore may not always follow the hy-
perbolic law (7–9). The hyperbolic para-
digm of the minimal model–derived DI
has also been criticized (10). Further-
more, its predictive power has not been
tested for large epidemiological studies.
In addition to the insulin-dependent
component of glucose tolerance (or DI),
theinsulin-independentcomponent(glu-
cose effectiveness [SG]) has already been
explored in mice (11) and humans (12).
SGisthecapacityofglucosetoenhanceits
own cellular uptake and to suppress en-
dogenous glucose production. Although
reducedinindividualswithimpairedglu-
cose tolerance (IGT) and diabetes (4,13),
SG contributes to glucose tolerance even
in conditions of signiﬁcant insulin resis-
tance, including diabetes (13). Reduced
SG has also been described in healthy in-
dividuals following the infusion of corti-
sol or glucagon, individuals in states of
verylowcaloricintake,womenwithpoly-
cystic ovary syndrome, and the elderly
(13–15). Contrary to the insulin sensitiv-
ityindex(SI),SGmaynotbeinﬂuencedby
exercise (16) or weight loss interventions
(17). In relatively small studies, SG has
been shown to predict future diabetes
(4,5,18),butitscontributiontothedevel-
opment of diabetes remains largely
unknown.
Since the hyperbolic paradigm has
not been tested in large epidemiological
studies, our ﬁrst objective was to analyze
the risk of future diabetes associated with
minimal model-derived DI relative to its
components, SI, and acute insulin re-
sponse(AIR).Thesecondobjectivewasto
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sulin-independent component of glucose
tolerance, SG, to the development of dia-
betes. To meet these aims, we used data
from the Insulin Resistance Atherosclero-
sis Study (IRAS), a multicenter observa-
tional epidemiological study of different
ethnic groups and varying states of glu-
cose tolerance (19).
RESEARCH DESIGN AND
METHODS— The design and meth-
ods of the IRAS have been described else-
where (19). Brieﬂy, the study was
conducted at four clinical centers. Cen-
ters in Oakland and Los Angeles, Califor-
nia, recruited non-Hispanic whites and
African Americans from Kaiser Perma-
nente, a nonproﬁt HMO. Two other cen-
ters in San Antonio, Texas, and San Luis
Valley, Colorado, recruited non-Hispanic
whites and Hispanics from two ongoing
population–based studies, the San Anto-
nio Heart Study and the San Luis Valley
Diabetes Study. A total of 1,625 individ-
uals were enrolled (56% women) be-
tween October 1992 and April 1994. A
follow-up examination was performed 5
years after the baseline examination
(range 4.5–6.6 years). The response rate
was 81%. Protocols were approved by lo-
cal institutional review committees. All
the participants gave written informed
consent.
The present report includes informa-
tion on 826 (79.2%) participants (332
non-Hispanic whites, 206 African Amer-
icans, and 288 Hispanics) after excluding
153 individuals who failed to return to
the follow-up visit and 64 individuals
with missing information on relevant
variables. Baseline characteristics were
similarintheparticipantsincludedinthis
analysis and those who were excluded
(e.g.,age,ethnicity,sex,glucosetolerance
status, BMI, waist circumference, and SI
[allcomparisons,P0.2])exceptforAIR
(higher in eligible participants, P 
0.005). Protocols were identical at the
baseline and follow-up examinations.
Eachexaminationrequiredtwovisits,one
week apart, of 4 h each. During the ﬁrst
visit,a75-goralglucosetolerancetestwas
administered to assess glucose tolerance
status.
During the second visit, insulin sen-
sitivity and ﬁrst-phase insulin secretion
weremeasuredbyFSIGTTwithtwomod-
iﬁcationstotheoriginalprotocol.First,an
injection of regular insulin was used to
ensure adequate plasma insulin levels for
the accurate computation of insulin sen-
sitivity across a broad range of glucose
tolerance (20). Second, the reduced sam-
pling protocol (12 samples) was used be-
cause of the large number of subjects. SI
and SG were calculated using mathemati-
cal modeling methods (MINMOD, ver-
sion 3.0 [1994], Los Angeles, California,
courtesy of Richard Bergman, PhD) (21).
AIR was calculated as the mean of 2- and
4-min insulin concentrations after glu-
coseadministrationandDIastheproduct
of SI and AIR.
Race/ethnicity was assessed by self-
report. Family history of diabetes was de-
ﬁned as diabetes in parents or siblings.
Anthropometric variables and blood
pressure were obtained by trained per-
sonnel. Plasma glucose and insulin con-
centrations were determined by the
glucose oxidase and dextran-charcoal ra-
dioimmunoassay methods, respectively.
This last assay displays a high degree of
cross-reactivity with proinsulin. The
1999 World Health Organization criteria
were used to deﬁne diabetes (fasting glu-
cose concentration 7.0 mmol/l, 2-h
plasma glucose concentration 11.1
mmol/l, or treatment with hypoglycemic
medications) and IGT (2-h plasma glu-
cose level between 7.8 and 11.1
mmol/l).
Statistical analyses
TheanalysiswascarriedoutusingtheSAS
statisticalsoftware(version9.1,SASInsti-
tute, Cary, NC). One-way ANCOVA or
logistic regression analysis was used to
comparethedifferencesforcontinuousor
dichotomous variables between groups,
respectively. Linear regression analyses
wereusedtoexaminetherelationofSGto
SI, AIR, and DI. In separate models, we
introduced the interaction term SG 
family history of diabetes. Results were
adjusted for demographic variables. Risk
of future diabetes associated with SI, AIR,
DI,andSGwasassessedbylogisticregres-
sion analysis. Odds ratios (ORs) were ex-
pressedforbinarytraitsorperSDincrease
for continuous traits. Demographic vari-
ables,familyhistoryofdiabetes,measures
ofobesity,andplasmaglucoseconcentra-
tionswerealsoincludedascovariates.We
assessed the impact of these covariates on
the relation of DI and SG to conversion to
diabetes by including appropriate inter-
action terms in separate logistic regres-
sion models. In both linear and logistic
regression models, log-transformed val-
ues of SI, AIR, and DI were used to im-
prove discrimination and calibration of
the models and to minimize the inﬂuence
of extreme observations. Given that some
individuals had SI and DI equal to zero,
we used the natural logarithms of SI  1
and DI  1 as the transformation for SI
andDI,respectively.Accuracyforthepre-
diction of diabetes was determined by the
area under the receiver operating charac-
teristic curve (AUC).
RESULTS— During the 5-year fol-
low-up period, 128 (15.5%) of 826 IRAS
participants developed type 2 diabetes:
44 (7.9%) of 557 participants with nor-
mal glucose tolerance at baseline, and 84
(31.2%) of 269 participants with IGT at
baseline.Thoseparticipantsconvertingto
type 2 diabetes did not differ from non-
convertersintermsofsexorethnicity(Ta-
ble 1). However, older age and family
history of diabetes were more common
among converters. Converters also had
higher BMI and waist circumference,
higher glucose and insulin levels, and
lower SI, AIR, DI, and SG.
In linear regression models, SG was
directly related to SI (parameter esti-
mate  1 SD, 0.11  0.02, P  0.001),
AIR (parameter estimate  1 SD, 0.22 
0.03, P  0.001), and DI (parameter es-
timate  1 SD, 0.29  0.05, P  0.001)
after accounting for the effects of age, sex,
race/ethnicity, and research center. There
was no interaction effect of family history
of diabetes on the relation of SG to SI (P 
0.534), AIR (P  0.139), and DI (P 
0.990).
WeusedtheAUCtoquantifytheabil-
ity of DI to predict conversion to diabetes
relativetothatofamodelwithbothSIand
AIR (found in the supplemental ﬁgure,
available in an online appendix at http://
care.diabetesjournals.org/cgi/content/
full/dc10-0165/DC1). The AUC of the
model with SI and AIR was similar to that
of DI (0.767 vs. 0.774, P  0.543). The
5-year incidence of diabetes by baseline
tertiles of SG and each one of the other
measures (SI, AIR, or DI) are presented in
Fig. 1.
SG predicted future development of
diabetes after adjusting for age, sex, race/
ethnicity, and research center (OR  1
SD,0.50[0.40–0.64]),asdidDI(OR1
SD, 0.47 [0.40–0.56]). In a multivariate
logisticregressionmodelthatincludedSG
andDIasindependentvariables,theodds
remained statistically signiﬁcant for both
SG(OR1SD,0.61[0.47–0.80])andDI
(OR1SD,0.68[0.54–0.85])(Table2).
Age, sex, race/ethnicity, research center,
familyhistoryofdiabetes,fastingglucose,
2-h glucose, BMI, and waist circumfer-
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differentmodelthatincludedSI,AIR,and
SG, these three measures were all inde-
pendent predictors of diabetes.
Inseparatelogisticregressionmodels,
we examined the impact of age, sex, race/
ethnicity, research center, BMI, glucose
tolerancestatus,familyhistoryofdiabetes
on the relationship between SG (or DI),
and incident diabetes. None of these vari-
ables had a signiﬁcant impact on the rela-
tionofSGandDItoconversiontodiabetes
(P  0.16 for all potential interactions)
exceptforageontherelationshipbetween
DI and conversion to diabetes (P 
0.038). The strength of the relation of DI
and SG to conversion to diabetes differed
little between categories of age, sex, race/
ethnicity, glucose tolerance status, BMI,
andfamilyhistoryofdiabetes(Fig.2A–F).
Additionally, the interaction term DI 
SG was not statistically signiﬁcant (P 
0.71). DI and SG were independent risk
factors across different degrees of insulin
sensitivity and insulin secretion (Fig. 2G
and H).
CONCLUSIONS — In cross-sectional
analyses, SG is directly related to insulin
sensitivity and ﬁrst-phase insulin secre-
tion. Further in prospective analyses, SG
andDIwerefoundtobeindependentpre-
dictors of conversion to diabetes similarly
across race/ethnic groups, varying states
of glucose tolerance, family history of di-
abetes, and obesity. The predictive power
of DI is comparable to that of the combi-
nation of SI and AIR.
Expanding a previous analysis by
Martin et al. (4), Goldﬁne et al. (5) exam-
ined the risk of conversion to diabetes as-
sociatedwithdirectlymeasuredDIin155
offspring of parents who both had type 2
diabetes and 181 subjects with normal
glucose tolerance and without family his-
tory of diabetes. DI predicted the devel-
opment of type 2 diabetes only in the
former group. Goldﬁne et al. concluded
that DI and particularly insulin resistance
was not sufﬁcient for the development of
diabetes in individuals without family
history of the disease. These individuals,
however, had a very low incidence of di-
abetes (6 cases during a mean follow-up
period of 25 years). In another study of
Pima Indians, incident diabetes was pre-
dicted by DI independent of the effect of
demographic variables and percentage of
bodyfat(7).Ourresultsvalidateprevious
studies and extend the ﬁndings to men
and women, all three race/ethnic groups,
and varying states of glucose tolerance,
family history of diabetes, and adiposity.
Ferrannini and Mari (10) have ques-
tioned the hyperbolic paradigm of the re-
lationship between insulin sensitivity and
ﬁrst-phase insulin secretion. In a recent
cross-sectionalstudy(22),however,these
authorsconﬁrmedtheparadigmwhilear-
guing against the compensation for insu-
lin resistance as the sole mechanism
responsible for hyperglycemia. They also
indicated that an intrinsic -cell function
defect is the most important mechanism
for hyperglycemia. In agreement with the
Table 1—Baseline characteristics by diabetes status at follow-up
Nonconvertors Convertors P
n 698 128
Age (years)* 54.4  0.3 56.5  0.7 0.009
Female (%)* 55.4 (51.7–59.1) 59.4 (50.7–67.5) 0.410
Ethnicity (%)* 0.647
African Americans 25.4 (22.3–28.7) 22.7 (16.2–30.7)
Mexican Americans 34.2 (30.8–37.8) 38.3 (30.3–47.0)
Non-Hispanic whites 40.4 (36.8–44.1) 39.1 (31.0–47.8)
Family history of diabetes (%) 37.6 (34.0–41.4) 50.6 (41.7–59.6) 0.001
BMI (kg/m
2) 27.8  0.2 30.8  0.5 0.001
Waist circumference (cm) 89.2  0.4 95.5  1.0 0.001
Fasting glucose (mmol/l) 5.35  0.02 5.83  0.05 0.001
2-h glucose (mmol/l) 6.61  0.06 8.37  0.15 0.001
Impaired glucose tolerance (%) 25.6 (22.6–29.2) 64.3 (55.3–72.4) 0.001
Fasting insulin (pmol/l)† 70.8  1.4 106.7  5.5 0.001
Insulin sensitivity index (SI)
( 10
4 min
1   	U
1   ml
1)† 1.92  0.06 1.03  0.13 0.001
Acute insulin response (AIR) (	U/ml)† 52.5  1.6 38.9  2.8 0.001
Disposition index (SI  AIR)† 96.5  2.9 41.2  3.4 0.001
Glucose effectiveness ( 100 min
1) 2.03  0.03 1.58  0.07 0.001
Data are n (%) with 95% CI or means  SD. Results are adjusted for age, sex, race/ethnicity, and research
center.*Unadjustedresults;†log-transformedvariables.Thesevariableswerethenback-transformedtotheir
units for presentation in the table.
Figure 1—Five-year incidence of diabetes by tertiles of SI, AIR, DI, and SG. Results were adjusted for age, sex, race/ethnicity, research center, IGT,
familyhistoryofdiabetes,andBMI.CutpointsfortertilesofSI(10
4min
1 U
1 ml
1)were1.16(lower),1.17–2.38(middle),and2.39
(upper).CorrespondingcutpointsfortertilesofAIR(U/ml)were37.5,38.0–75.0,and75.5;DI(10
4min
1 U
1 ml
1perU ml
1)
55.8, 55.9–120.0, and 120.1; SG ( 10
2 ml
1), 1.58, 1.59–2.22, and 2.23.
Disposition index and glucose effectiveness
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that the predictive power of DI is compa-
rable with that of its components. DI,
however, is not the only independent risk
factor for the development of diabetes.
Since fasting and 2-h plasma glucose val-
ues remain strong predictors of diabetes,
we cannot disregard other determinants
ofglucosehomeostasis,suchasadditional
aspects of secretory response to glucose
stimulation (e.g., -cell glucose sensitiv-
ity and potentiation), from the disease
process.
Lopez et al. (23) recently reported
that SG is related to SI in individuals with
family history of diabetes but not in those
without such a history. Our results, how-
ever, indicate that family history of diabe-
tes has little inﬂuence on the relationship
between SG and SI. This is not surprising.
SG is independent of the dynamic insulin
response but is inﬂuenced by the basal
insulin level (13). In other words, SG is
inﬂuenced by the effect of insulin on glu-
cose uptake by insulin-dependent tissues
(basal insulin–dependent component)
(12). Similarly, in longitudinal studies by
Martinetal.(4)andGoldﬁneetal.(5),SG
predicted conversion to diabetes inde-
Table 2—Predictors of conversion to type 2 diabetes by multiple logistic regression analysis
OR (95% CI) P
Model 1*
Age ( 1 SD) 1.09 (0.87–1.38) 0.449
Female vs. male 0.93 (0.52–1.69) 0.824
Family history of diabetes (yes vs. no) 1.25 (0.79–1.96) 0.340
BMI ( 1 SD) 1.33 (0.87–2.05) 0.187
Waist circumference ( 1 SD) 0.74 (0.47–1.18) 0.206
Fasting glucose concentration ( 1 SD) 1.60 (1.24–2.06) 0.001
2-h glucose concentration ( 1 SD) 1.95 (1.48–2.57) 0.001
Disposition index ( 1 SD)† 0.68 (0.54–0.85) 0.001
Glucose effectiveness ( 1 SD) 0.61 (0.47–0.80) 0.001
Model 2‡
Age ( 1 SD) 1.10 (0.87–1.39) 0.422
Female vs. male 0.91 (0.50–1.65) 0.754
Family history of diabetes (yes vs. no) 1.25 (0.80–1.96) 0.328
BMI ( 1 SD) 1.39 (0.90–2.14) 0.137
Waist circumference ( 1 SD) 0.72 (0.45–1.17) 0.190
Fasting glucose concentration ( 1 SD) 1.54 (1.18–2.00) 0.001
2-h glucose concentration ( 1 SD) 1.91 (1.44–2.53) 0.001
Insulin sensitivity index ( 1 SD)† 0.61 (0.44–0.86) 0.004
Acute insulin response ( 1 SD)† 0.73 (0.55–0.95) 0.022
Glucose effectiveness ( 1 SD) 0.67 (0.50–0.88) 0.005
ORs expressed for binary traits or per 1 SD unit change for continuous traits. *Results in Model 1 adjusted
also for race/ethnicity (P  0.494) and research center (P  0.006); †log-transformed variables; ‡results in
Model 2 also adjusted for race/ethnicity (P  0.446) and research center (P  0.006).
Figure 2—Risk of developing diabetes associated with DI and SG by ethnicity, sex, glucose tolerance status, BMI and age categories, family history
of diabetes, and tertiles of SI and AIR. Estimates expressed fora1S Dunit change. Age, sex, race/ethnicity, research center, BMI, IGT, family history
of diabetes, DI, and SG were all included as independent variables in all eight models. Log-transformed values of DI were used to improve
discrimination and calibration of the models and to minimize the inﬂuence of extreme observations.
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type 2 diabetic parents. Individuals with-
out family history of diabetes had a very
low risk of future diabetes and neither SG
nor DI predicted diabetes. Osei et al. (18)
examined the risk of progression to IGT
or diabetes associated with SG in 81 ﬁrst-
degreerelativesofAfricanAmericanswith
type2diabetes.SGaswellasdirectlymea-
sured insulin resistance and secretion
were independent predictors of worsen-
ing glucose tolerance status. Neverthe-
less, none of these studies adjusted their
results for glucose tolerance status and
adiposity. In the IRAS, SG is an indepen-
dent risk factor for future diabetes in in-
dividuals with family history of diabetes
andsimilarresultsaredemonstratedinall
other categories regardless of age, sex, race/
ethnicity, glucose tolerance, and adiposity.
SGisdirectlyrelatedtoﬁrst-phaseinsu-
lin secretion. Experiments in canines have
suggestedthatthisrelationshipisanartifact
oftheminimalmodelmethod(24).Inmice,
however, the effect of ﬁrst-phase insulin se-
cretion (in physiological conditions) on SG
isminimal(20).Furthermore,FSIGTTwith
the minimal model analysis may overesti-
mate SG. In human subjects, the difference
between minimal model- and clamp-
derived SG appears to be related to the as-
sumption of mono-compartmental
distribution of glucose by the minimal
modelanalysis;however,bothmeasuresare
highly correlated (25). Therefore, minimal
model-derived SG is considered an ade-
quate measure of nonsteady-state glucose
kinetics and a dependable index.
Inconclusion,thepredictivediscrim-
inationofDIforfuturediabetesiscompa-
rable with that of the combination of SI
and AIR; therefore, our results support
the validity of the hyperbolic paradigm.
DIandSGareimportant,independentde-
terminants of diabetes in different ethnic
groups and varying states of glucose tol-
erance, family history of diabetes, and
obesity. SG has a direct relationship with
SI and AIR. Prospective studies are
needed to examine the natural course of
SGrelativetothatofinsulinresistanceand
-cell function.
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